COSMOS Pharmaceutical Corporation
3349.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | ¥698,574 | ¥699,998 | ¥558,209 | ¥585,315 |
| - Cash | ¥49,538 | ¥57,038 | ¥22,765 | ¥39,129 |
| + Debt | ¥41,546 | ¥49,957 | ¥28,529 | ¥25,675 |
| Enterprise Value | ¥690,582 | ¥692,917 | ¥563,973 | ¥571,861 |
| Revenue | ¥272,394 | ¥259,122 | ¥246,332 | ¥244,095 |
| % Growth | 5.1% | 5.2% | 0.9% | – |
| Gross Profit | ¥57,175 | ¥54,073 | ¥53,134 | ¥51,511 |
| % Margin | 21% | 20.9% | 21.6% | 21.1% |
| EBITDA | ¥17,947 | ¥15,306 | ¥17,421 | ¥14,169 |
| % Margin | 6.6% | 5.9% | 7.1% | 5.8% |
| Net Income | ¥8,171 | ¥8,635 | ¥7,915 | ¥6,285 |
| % Margin | 3% | 3.3% | 3.2% | 2.6% |
| EPS Diluted | 103.09 | 108.95 | 99.86 | 79.3 |
| % Growth | -5.4% | 9.1% | 25.9% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |